Pancreatic Cancer News & Features
Researchers have shown that a certain protein becomes overabundant in pancreatic neuroendocrine tumors, allowing them to thrive. They also found that pairing a synthetic compound with an existing drug provides a more effective anticancer punch than a single drug.
Use of irreversible electroporation (IRE) doubles survival time for patients with locally advanced pancreatic cancer.
Study found IRE procedure improved survival for people with stage III disease.
A new set of genes has been identified that can indicate improved survival after surgery for patients with pancreatic cancer. The study also showed that detection of circulating tumor DNA in the blood could provide an early indication of tumor recurrence.
Scientists have identified a molecular partnership in pancreatic cancer cells that might help to explain how the disease metastasizes.
- Clinical Trial Shows Vaccine Clears Some Precancerous Cervical Lesions
- Late-Stage Lung Cancer Often Overtreated
- Biomarker May Predict Prognosis for Targeted Therapy in Patients With HER2-Negative Breast Cancer
- New Approach Tackles Hormone Therapy Resistance in Breast Cancer
- Patients With Multiple Myeloma Vulnerable to Financial Toxicity Due to Costly Treatments
- CT Scans for Lung Cancer Result in Low Number of False-Positives
- Artificial Intelligence May Better Predict Response in Breast Cancer Treatment
- Blood Source May Explain Low Numbers of Circulating Tumor Cells in Liquid Biopsies
- Engineered Switch in Immune Cell Technology Makes Therapy More Precise, and Safer
- Testosterone Therapy Does Not Increase Aggressive Prostate Cancer Risk
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|